Joel S. Freundlich
Associate Professor
Chemical Engineering
The State University of New Jersey
United States of America
Biography
Dr. Freundlich received his B.S. and M. Eng. degrees in Chemical Engineering from Cornell University and his Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology in the laboratory of 2005 Chemistry Nobel Prize laureate Richard R. Schrock. He spent ten years in the biotech/pharmaceutical industry, contributing to multiple IND submissions before moving to the department of Biochemistry and Biophysics at Texas A&M University as a senior scientist. He arrived at NJMS in 2011 to continue his work in infectious diseases. Currently, Dr. Freundlich is an associate professor in the Department of Medicine, Division of Infectious Diseases and The Center for Emerging and Re-emerging Pathogens, and the Department of Pharmacology and Physiology.His laboratory studies how the pathogen adapts to life within the host and, in turn, how the host responds to the infection. Currently, Mycobacterium tuberculosis and Plasmodium falciparum, the causative agents of tuberculosis and malaria, respectively, are of chief interest. The Freundlich lab seeks to leverage chemical techniques to study the essential pathogen biology and the host immune response to identify and validate biological targets and to seed the development of novel therapeutics. Dr. Freundlich received his B.S. and M. Eng. degrees in Chemical Engineering from Cornell University and his Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology in the laboratory of 2005 Chemistry Nobel Prize laureate Richard R. Schrock. He spent ten years in the biotech/pharmaceutical industry, contributing to multiple IND submissions before moving to the department of Biochemistry and Biophysics at Texas A&M University as a senior scientist. He arrived at NJMS in 2011 to continue his work in infectious diseases. Currently, Dr. Freundlich is an associate professor in the Department of Medicine, Division of Infectious Diseases and The Center for Emerging and Re-emerging Pathogens, and the Department of Pharmacology and Physiology.His laboratory studies how the pathogen adapts to life within the host and, in turn, how the host responds to the infection. Currently, Mycobacterium tuberculosis and Plasmodium falciparum, the causative agents of tuberculosis and malaria, respectively, are of chief interest. The Freundlich lab seeks to leverage chemical techniques to study the essential pathogen biology and the host immune response to identify and validate biological targets and to seed the development of novel therapeutics.
Research Interest
Chemical Engineering
